MyFinsight
Home
Blog
About
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
Income Overview
Net Income
-$8,378K
EPS
-$0.13
Unit: Thousand (K) dollars
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Income Statement
2025-09-30
2025-06-30
Research and development
13,742
16,652
General and administrative
5,613
6,518
Total operating expenses
19,355
23,170
Loss from operations
-19,355
-23,170
Currency exchange gain (loss), net
98
-374
Interest income
255
285
Interest expense
886
253
Change in fair value of warrants (note 3)
-9,846
2,587
Total other income (expense), net
9,313
-2,929
Loss before income tax expense (credit)
-10,042
-26,099
Income taxes expense
-
118
Income tax (credit) expense
-1,664
100
Net loss
-8,378
-26,217
Net loss attributable to common shareholders
-8,378
-26,217
Basic EPS
-0.13
-0.4
Diluted EPS
-0.13
-0.4
Basic Average Shares
66,941,964
65,880,914
Diluted Average Shares
66,941,964
65,880,914
Page 1
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Income Statement
Net loss
attributable to common...
-$8,378K
Net loss
-$8,378K
Income tax (credit)
expense
-$1,664K
Change in fair value of
warrants (note 3)
-$9,846K
Interest income
$255K
Currency exchange gain
(loss), net
$98K
Loss before income
tax expense...
-$10,042K
Total other income
(expense), net
$9,313K
Interest expense
$886K
Loss from operations
-$19,355K
Total operating
expenses
$19,355K
Research and development
$13,742K
General and
administrative
$5,613K
Buy us a coffee
IO Biotech, Inc. (IOBT)
IO Biotech, Inc. (IOBT)